Icatibant
Icatibant is a prescription medication used to treat acute attacks of hereditary angioedema, a rare genetic disorder causing swelling in the skin, airways, or intestines. It works by blocking bradykinin, a substance that triggers swelling. Administered as a subcutaneous injection (under the skin), each dose contains 30 mg of icatibant acetate in a 3 mL syringe. Manufactured by Alembic Pharmaceuticals, it's available in packs of 1 or 3 syringes. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Icatibant is a prescription medication used to treat acute attacks of hereditary angioedema, a rare genetic disorder causing swelling in the skin, airways, or intestines. It works by blocking bradykinin, a substance that triggers swelling. Administered as a subcutaneous injection (under the skin), each dose contains 30 mg of icatibant acetate in a 3 mL syringe. Manufactured by Alembic Pharmaceuticals, it's available in packs of 1 or 3 syringes. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Icatibant", "mediaType": "text/html", "description": " Access the FDA dataset for Icatibant — ANDA 211021 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211021" } ] |
| identifier | ANDA211021 |
| issued | 2016-09-16 |
| keyword |
[ "drug-manufacturers", "fda", "medications", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Icatibant |
